CVE-2023-38955
CVE-2023-38955 is a high-severity vulnerability in Zkteco Bioaccess Ivs with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-668.
Key facts
- Severity: High (CVSS 3.x base score 7.5)
- EPSS exploit prediction: 1% (39th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-668
- Affected product: Zkteco Bioaccess Ivs
- Published:
- Last modified:
Description
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
Frequently asked questions
- What is CVE-2023-38955?
- ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
- How severe is CVE-2023-38955?
- CVE-2023-38955 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
- Is CVE-2023-38955 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (39th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-38955?
- CVE-2023-38955 affects Zkteco Bioaccess Ivs. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-38955?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2023-38955 published?
- CVE-2023-38955 was published on 2023-08-03 and last updated on 2026-07-09.
References
Affected products (1)
- cpe:2.3:a:zkteco:bioaccess_ivs:3.3.1:*:*:*:*:*:*:*
More vulnerabilities in Zkteco Bioaccess Ivs
- CVE-2023-38954 — Critical (CVSS 9.8): ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.
- CVE-2023-38956 — High (CVSS 7.5): A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files…
- CVE-2023-38958 — Medium (CVSS 5.3): An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open…
All CVEs affecting Zkteco Bioaccess Ivs →
Other CWE-668 (Exposure of Resource to Wrong Sphere) vulnerabilities
- CVE-2025-2857 — Critical (CVSS 10.0): Following the recent Chrome sandbox escape (CVE-2025-2783), various Firefox developers identified a similar pattern in…
- CVE-2019-8779 — Critical (CVSS 10.0): A logic issue applied the incorrect restrictions. This issue was addressed by updating the logic to apply the correct…
- CVE-2012-1846 — Critical (CVSS 10.0): Google Chrome 17.0.963.66 and earlier allows remote attackers to bypass the sandbox protection mechanism by leveraging…
- CVE-2022-43684 — Critical (CVSS 9.9): ServiceNow has released patches and an upgrade that address an Access Control List (ACL) bypass issue in ServiceNow…
- CVE-2022-24900 — Critical (CVSS 9.9): Piano LED Visualizer is software that allows LED lights to light up as a person plays a piano connected to a computer.…
- CVE-2019-16541 — Critical (CVSS 9.9): Jenkins JIRA Plugin 3.0.10 and earlier does not declare the correct (folder) scope for per-folder Jira site…
Browse all CWE-668 (Exposure of Resource to Wrong Sphere) vulnerabilities →